Blood Journal

Leading the way in experimental and clinical research in hematology

First Edition


  • Advances in Hematology: Laurie Sehn, MDCM, MPH

    Dr. Laurie Sehn discusses recent advancements in the treatment of patients with lymphoma including new therapies that are designed to target a specific individuals molecular biology.

  • Author Voices: Brad Kahl, MD

    Kahl, B. S., Spurgeon, S. E., Furman, R. R., Flinn, I. W., Coutre, S. E., Brown, J. R., … Wagner-Johnston, N. D. (2014). A phase 1 study of the PI3Kδ inhibitor idelalisib in patients with relapsed/refractory mantle cell lymphoma (MCL). Blood, 123(22), 3398–3405.

  • Meet the Editor: John G. Gribben, MD, DSc, FRCPath

    Dr. John G. Gribben provides insight into the kind of papers that Blood is looking to publish; specifically work that is novel, innovative, and having an impact on how hematologists think about a topic or make a difference in patient's treatments.

View all Multimedia